The Cigna Group (CI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
Cash Flows From Operating Activities | |||||
Net Income | 2,646,000 | 2,232,000 | 1,843,000 | 2,077,000 | 2,094,000 |
Depreciation Amortization | 695,000 | 566,000 | 610,000 | 585,000 | 588,000 |
Income taxes - deferred | -101,000 | 242,000 | 74,000 | 21,000 | -22,000 |
Accounts payable and accrued liabilities | -510,000 | 731,000 | 125,000 | 423,000 | 202,000 |
Other Working Capital | 449,000 | 962,000 | 1,668,000 | 207,000 | -348,000 |
Other Operating Activity | 591,000 | -647,000 | -294,000 | -380,000 | -356,000 |
Operating Cash Flow | $3,770,000 | $4,086,000 | $4,026,000 | $2,933,000 | $2,158,000 |
Cash Flows From Investing Activities | |||||
PPE Investments | -528,000 | -471,000 | -461,000 | -510,000 | -473,000 |
Net Acquisitions | -24,455,000 | -209,000 | -4,000 | -99,000 | N/A |
Purchase Of Investment | -7,138,000 | -7,123,000 | -7,054,000 | -5,917,000 | -7,826,000 |
Sale Of Investment | 5,755,000 | 6,100,000 | 5,046,000 | 4,790,000 | 6,457,000 |
Other Investing Activity | -12,000 | 0 | -101,000 | 0 | -24,000 |
Investing Cash Flow | $-26,378,000 | $-1,703,000 | $-2,574,000 | $-1,736,000 | $-1,866,000 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | 1,487,000 | 80,000 | -148,000 | -21,000 | -112,000 |
Debt Issued | 22,856,000 | 1,581,000 | N/A | 894,000 | 0 |
Debt Repayment | -131,000 | -1,563,000 | N/A | -938,000 | 0 |
Common Stock Issued | 68,000 | 131,000 | 36,000 | 154,000 | 110,000 |
Common Stock Repurchased | -342,000 | -2,725,000 | -139,000 | -671,000 | -1,612,000 |
Other Financing Activity | -423,000 | -155,000 | 26,000 | -27,000 | -21,000 |
Financing Cash Flow | $23,515,000 | $-2,651,000 | $-225,000 | $-609,000 | $-1,635,000 |
Exchange Rate Effect | -24,000 | 55,000 | -10,000 | -40,000 | -32,000 |
Beginning Cash Position | 2,972,000 | 3,185,000 | 1,968,000 | 1,420,000 | 2,795,000 |
End Cash Position | 3,855,000 | 2,972,000 | 3,185,000 | 1,968,000 | 1,420,000 |
Net Cash Flow | $883,000 | $-213,000 | $1,217,000 | $548,000 | $-1,375,000 |
Free Cash Flow | |||||
Operating Cash Flow | 3,770,000 | 4,086,000 | 4,026,000 | 2,933,000 | 2,158,000 |
Capital Expenditure | -528,000 | -471,000 | -461,000 | -510,000 | -473,000 |
Free Cash Flow | 3,242,000 | 3,615,000 | 3,565,000 | 2,423,000 | 1,685,000 |